Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • frymor
    Senior Member
    • May 2010
    • 151

    #1

    How to differentiate between PCR duplicates and real data?

    Hi,

    After IMHO intensive search in the internet for help, I must admit that i couldn't find anything too helpful, so I would like to ask here if there is a reasonable explanation or method to do that.

    I am working with mRNA-Seq from Drosophila and after running the fastqc software got a very high duplication level.
    I explaind it more specifically here (http://seqanswers.com/forums/showthr...1804#post31804), But as I think that it is an important question (at least for me), I would like to ask it separately again here.
    It will be nice to get some data from both sides of the analysis. If someone has data of PCR duplications he/she can give, I would like to have a look at it.

    Was it expected to have something like that in a RNA-Seq experiment?

    How can someone reliably differentiate between the two cases?

    Thanks for the help

    Assa
  • son_nexg
    Junior Member
    • Jul 2011
    • 8

    #2
    Hi Just to add to the above question - Could estimate amount of PCR duplication in the RNA-seq data ?

    Thank you!

    Comment

    • robs
      Senior Member
      • May 2010
      • 116

      #3
      There are some papers on this topic if you search in Google Scholar and other posts at seqanswer that discussed this topic (use the search function).

      The short answer is that you can't tell for sure if the read is artificial or real. It is dependent on a number of factors such as sequencing technology used, expected coverage, read length, etc. There are some approaches that make some assumptions to identify artificial duplicates (e.g. metagenomic reads starting with the same bases are assumed to be duplicates).

      I see a similar number of duplicates for 454/Roche sequencing independent of the type of sample sequenced (metagenome, metatranscriptome, ...).

      Maybe you can give some more details about your data.

      Comment

      • son_nexg
        Junior Member
        • Jul 2011
        • 8

        #4
        Thanks for your reply 'robs'.

        I will have a look at the literature on this.
        I was just wondering about it ... so far I was dealing with the DNA seq data and I would expect roughly 10% duplicates in a typical run. But with RNA-seq the story is little different. We start with a very-2 low amount of starting ploy-A capture RNA and then have to amplify it many fold to get decent amount for the sequencing run. Which makes it more prune to having PCR duplicates in the final data.

        I can see people are working on protocols for transcriptome data where you can do away with PCR amplification step (e.g. http://www.nature.com/nmeth/journal/...meth.1417.html) but as of now Illumina's protocols use PCR and we need to have reasonal filters to get some real information out of the sequence data.

        Comment

        • james hadfield
          Moderator
          Cambridge, UK
          Community Forum
          • Feb 2008
          • 224

          #5
          you could add a 4bp random sequence in your barcode read or at the 5'end of your oligo for ligation. This way you can see if a read is a duplicate of PCR. You should not see the same random sequence, unless PCR has amplified it so.

          Comment

          • rskr
            Senior Member
            • Oct 2010
            • 249

            #6
            If 90% of the reads in your data is identical to one read, then they are probably duplicates

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Working...